Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
Hims & Hers (HIMS) CEO Andrew Dudum defended the company against an FTC lawsuit, citing its revenue growth and subscriber base. Q2 revenue rose 40% YoY to $753M, with a full-year forecast of $3.1B-$3.3B. However, margins fell to 64% from 76%, and free cash flow was negative $68M, raising concerns about profitability and legal risks.
How this was made

The 30-second read
Why it matters
Earnings beat on revenue but margin compression and regulatory risk create a mixed outlook.
Market read
The earnings release and regulatory exposure are material for traders evaluating HIMS.
What to watch
Potential for settlement or policy clarification that may limit downside.
Background
Hims & Hers disclosed Q2 results and raised FY guidance while defending its GLP‑1 subscription model against an FTC lawsuit.
Ticker impact
Q2 revenue jumped 40% YoY to $753M and full-year forecast raised to $3.1‑3.3B, while the FTC lawsuit remains active.
Potential short‑term pullback on lawsuit concerns, with upside if guidance holds.
Strong top‑line growth offsets margin decline; however, FTC action adds downside risk that could weigh on the stock.
Market effects
Highlights regulatory scrutiny on telehealth subscription models, affecting peers in digital health.
U.S. digital health stocks may see heightened volatility.
Signals potential regulatory ripple for global telemedicine firms.
Counterpoint
Despite the FTC suit, the rapid subscriber growth could justify a bullish stance.
Key entities
- CEOAndrew Dudum
Provided commentary on FTC lawsuit and growth strategy.
- RegulatorFederal Trade Commission
Suing Hims & Hers over data‑sharing and subscription practices.


